Kulkarni Samarth (CIK 1682019) reported 29 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-24). Recent activity: Buy CRSP (19,687 shares), Sell CRSP (10,020 shares), Buy CRSP (20,625 shares), Sell CRSP (10,349 shares), Buy CRSP (19,250 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 19,687 | $0 |
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 10,020 | $468,736 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 20,625 | $0 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 10,349 | $499,443 |
| 2026-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 19,250 | $0 |
| 2026-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 9,798 | $517,334 |
| 2026-02-20 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 13,250 | $0 |
| 2026-02-20 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 6,967 | $366,325 |
| 2026-01-22 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 21,433 | $1.1M |
| 2026-01-22 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 8,567 | $446,341 |
| 2026-01-22 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 60,000 | $3.6M |
| 2025-12-22 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 30,000 | $0 |
| 2025-10-20 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 100,000 | $0 |
| 2025-10-20 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 50,895 | $3.5M |
| 2025-10-15 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 8,334 | $0 |
| 2025-10-15 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 4,242 | $282,517 |
| 2025-09-19 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 6,000 | $0 |
| 2025-08-19 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 25,000 | $0 |
| 2025-08-19 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 13,081 | $760,660 |
| 2025-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 19,688 | $0 |
| 2025-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 10,031 | $413,578 |
| 2025-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 19,250 | $0 |
| 2025-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 9,973 | $423,055 |
| 2025-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Buy | 9,000 | $0 |
| 2025-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | Sell | 4,462 | $193,294 |
Source: SEC Form 4 filings · as of 2026-03-24